文献速递心血管腹部CT

冠状动脉CT血管成像中的肝脂肪变与动脉粥样硬化斑块

Hepatosteatosis and Atherosclerotic Plaque at Coronary CT Angiography.
PubMed 文献 · Radiol Cardiothorac Imaging · 2022-04-28

本项苏格兰心脏CT试验的事后分析纳入1726名参与者,在非增强CT上测量肝脂肪变和冠状动脉钙化积分,在冠状动脉CT血管成像上评估狭窄、高危斑块及定量斑块负荷。肝脂肪变组冠状动脉钙化积分更高、非阻塞性病变更多、低衰减斑块负荷更高,但校正心血管危险因素后关联不再独立,心肌梗死发生率无差异。

要点

  • 肝脂肪变患者冠状动脉钙化积分中位数43 AU,高于无肝脂肪变者的19 AU(P=.046)。
  • 肝脂肪变组非阻塞性病变48%,高于无肝脂肪变组的37%(P=.02)。
  • 肝脂肪变组低衰减斑块负荷5.11%,高于无肝脂肪变组的4.07%(P=.04)。

核心结论

  • CT检出的肝脂肪变与冠状动脉疾病患病率升高相关,但校正心血管危险因素后关联不再独立;中位4.7年随访中心肌梗死发生率在有无肝脂肪变者间无差异(1.9% vs 2.4%,P=.92)。

研究设计与样本

  • 本项为前瞻性苏格兰心脏CT试验(2010年11月至2014年9月)的事后分析,纳入1726名参与者(平均年龄58岁±9[SD],974名男性),在非增强CT上测量肝脂肪变和冠状动脉钙化积分,在冠状动脉CT血管成像上评估狭窄、视觉评估的高危斑块和定量斑块负荷。

关键影像表现/征象

  • 肝脂肪变患者冠状动脉钙化积分中位数43 Agatston单位(四分位距0-273),无肝脂肪变者为19 Agatston单位(0-225),P=.046。
  • 肝脂肪变组非阻塞性病变占48%,无肝脂肪变组占37%,P=.02。
  • 肝脂肪变组低衰减斑块负荷为5.11%(0-7.16),无肝脂肪变组为4.07%(0-6.84),P=.04。

局限性

  • 原文为事后分析。
  • 肝脂肪变与冠状动脉疾病的关联在校正心血管危险因素后不再独立。
  • 中位随访4.7年期间有无肝脂肪变者心肌梗死发生率无差异(1.9% vs 2.4%,P=.92)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the association between nonalcoholic fatty liver disease (NAFLD) and quantitative atherosclerotic plaque at CT.

MATERIALS AND METHODS: In this post hoc analysis of the prospective Scottish Computed Tomography of the HEART trial (November 2010 to September 2014), hepatosteatosis and coronary artery calcium score were measured at noncontrast CT. Presence of stenoses, visually assessed high-risk plaque, and quantitative plaque burden were assessed at coronary CT angiography. Multivariable models were constructed to assess the impact of hepatosteatosis and cardiovascular risk factors on coronary artery disease.

RESULTS: Images from 1726 participants (mean age, 58 years ± 9 [SD]; 974 men) were included. Participants with hepatosteatosis (155 of 1726, 9%) had a higher body mass index, more hypertension and diabetes mellitus, and higher cardiovascular risk scores (P < .001 for all) compared with those without hepatosteatosis. They had increased coronary artery calcium scores (median, 43 Agatston units [AU] [interquartile range, 0-273] vs 19 AU [0-225], P = .046), more nonobstructive disease (48% vs 37%, P = .02), and higher low-attenuation plaque burden (5.11% [0-7.16] vs 4.07% [0-6.84], P = .04). However, these associations were not independent of cardiovascular risk factors. Over a median of 4.7 years, there was no evidence of a difference in myocardial infarction between those with and without hepatosteatosis (1.9% vs 2.4%, P = .92).

CONCLUSION: Hepatosteatosis at CT was associated with an increased prevalence of coronary artery disease at CT, but this was not independent of the presence of cardiovascular risk factors.Keywords: CT, Cardiac, Nonalcoholic Fatty Liver Disease, Coronary Artery Disease, Hepatosteatosis, Plaque QuantificationClinical trial registration no. NCT01149590 Supplemental material is available for this article. © RSNA, 2022See also commentary by Abohashem and Blankstein in this issue.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Carter, Heseltine, Meah, et al. Hepatosteatosis and Atherosclerotic Plaque at Coronary CT Angiography. Radiol Cardiothorac Imaging. 2022. PMID: 35506136. doi:10.1148/ryct.210260

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。